tobacco News & Analysis
6 articles
Market Mood
Philip Morris (PM) Gains FDA Approval for Zyn Marketing
The FDA has authorized Philip Morris International (PM) to promote Zyn as a reduced-risk product compared to traditional cigarettes. This approval could impact consumer behavior and market dynamics in the tobacco sector. Philip Morris aims to transition smokers to potentially less harmful alternatives, aligning with public health goals. Market analysts may view this development as a strategic advantage for PM in the evolving tobacco landscape.
Read More
FDA Approves Zyn Nicotine Pouches Sales as Less Harmful for Philip Morris
The FDA authorized 20 Zyn nicotine pouch products owned by Philip Morris (PM) to be marketed with claims of being less harmful than traditional cigarettes. This regulatory approval represents a significant win for PM as it allows the company to promote its products as lowering risks associated with several smoking-related diseases. The FDA's decision does not indicate that Zyn is safe, reiterating that there's no safe tobacco product. This move aligns with a broader trend of declining cigarette sales and increasing investment in smoke-free alternatives by major tobacco companies.
Read More
Metcash FY26 Presentation: Diversification Offsets Tobacco Decline
Metcash (MTS) provided insights during its FY26 presentation, highlighting diversification strategies that have mitigated declines in tobacco sales. The company has reported a steady performance despite challenges within the tobacco sector, indicating that its efforts in expanding other segments are effective. This diversification is crucial in maintaining revenue stability and possibly enhancing growth prospects for MTS. Continued investments in non-tobacco areas may strengthen the company's market position moving forward.
Read More
Altria (MO) Price Target Raised to $64 by Barclays
On May 15, Barclays increased its price target on Altria Group, Inc. (MO) to $64 from $63 while maintaining an Underweight rating. The firm cited recent FDA guidance prompting potential innovations in the tobacco sector. During Q1 2026, CEO William Gifford reported a 7.3% increase in adjusted diluted EPS and noted shipment volumes for the on! portfolio grew nearly 18%, exceeding 46 million cans. These developments suggest that Altria’s strong cash flow could support shareholder returns through dividends and buybacks, highlighting ongoing growth opportunities in the market.
Read More
Highest-Yielding Dividend Kings: Altria (MO) 6.3% Yield in April
In April, Altria (MO) offers a dividend yield of 6.3%, significantly higher than the S&P 500's yield of approximately 1.1%. Universal Corporation (UVV) follows closely with a 6.1% yield, operating globally and providing tobacco to other production companies. Both companies are categorized as Dividend Kings, having raised dividends for at least 50 consecutive years. Their ability to maintain payouts is attributed to strong cash flows, despite challenges in cigarette demand, especially for Altria, which primarily sells cigarettes in North America.
Read More
Jefferies Names Top Tobacco Stocks Amid Nicotine Pouch Trends
Limited data available — The article discusses Jefferies' selection of top tobacco stocks amidst increasing competition from nicotine pouches. It highlights the shifting dynamics in the tobacco industry without providing specific trading volumes, P/E ratios, or market impacts. The mention of emerging trends in nicotine products suggests potential changes in consumer behavior, but no concrete data points are provided to assess market implications. As such, the overall sentiment is neutral owing to the lack of quantifiable information.
Read More